WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Michael Thompson, MD, PhD
800
Academic contribution (See all users)

By role

800
Editor

By subject area

500
Oncology
200
Translational Medicine
200
Health policy
200
Clinical trials
200
Evidence Based Medicine
100
Otorhinolaryngology
100
Statistics
100
Drugs and Devices
100
Surgery and Surgical Specialties
100
Clinical Trials
100
Pharmacology
100
Drugs and devices
100
Gastroenterology and Hepatology
100
Medical Genetics
100
Science policy
100
Human-Computer interaction
100
Hematology
100
Translational medicine
100
Emergency and Critical Care
Academic Editor

Michael A Thompson, MD, PhD

Summary

I am passionate about clinical trials, translational and basic science research. It is a tragedy that only 2-7% of adults participate in cancer clinical trials. The treatment standards of care we have today in oncology are built upon the clinical trial leadership and patient participation of the past. I am interested in: early phase (I/II) clinical trials, precision medicine, multiple myeloma and other B-cell malignancies (CLL, lymphoma, etc).

Clinical Trials Oncology

Work details

Medical Director Early Phase Cancer Research Program

Aurora Research Institute
Hematology/Oncology

Co-Director, Oncology Precision Medicine Program

Aurora Health Care
Aurora Cancer Care

Co-PI Aurora NCORP

Aurora Health Care

Websites